Pelvic floor behavioral treatment for fecal incontinence and constipation in quiescent inflammatory bowel disease

References

• Perera LP, Radigan M, Guilday C, et al. Presence of irritable bowel syndrome symptoms in quiescent inflammatory bowel disease is associated with high rate of anxiety and depression. Dig Dis Sci. 2019;64(7):1923–1928.
   PubMed Web of Science ®Google Scholar
• Ng KS, Sivakumaran Y, Nassar N, et al. Fecal incontinence: community prevalence and associated factors – a systematic review. Dis Colon Rectum. 2015;58(12):1194–1209.
   PubMed Web of Science ®Google Scholar
• Gu P, Kuenzig ME, Kaplan GG, et al. Fecal incontinence in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2018;24(6):1280–1290.
   PubMed Web of Science ®Google Scholar
• Lonnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life – discovering the true impact. J Crohns Colitis. 2014;8(10):1281–1286.
   PubMed Web of Science ®Google Scholar
• Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(9):1582–1591.
   PubMed Web of Science ®Google Scholar
• Mavroudis G, Simren M, Jonefjall B, et al. Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease. Therap Adv Gastroenterol. 2019;12:175628481982768.
   Web of Science ®Google Scholar
• Norton C, Dibley L. Help-seeking for fecal incontinence in people with inflammatory bowel disease. J Wound Ostomy Continence Nurs. 2013;40(6):631–638.
   PubMed Web of Science ®Google Scholar
• Colombel JF, Shin A, Gibson PR. AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: expert review. Clin Gastroenterol Hepatol. 2019;17(3):380–390 e1.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Gu P, Kaplan GG, et al. Dyssynergic defecation in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2018;24(5):1065–1073.
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Levy RL, Crowell MD, et al. Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1355–1367.
   Web of Science ®Google Scholar
• Bryant RV, van Langenberg DR, Holtmann GJ, et al. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol. 2011;26(5):916–923.
   PubMed Web of Science ®Google Scholar
• Farrokhyar F, Marshall JK, Easterbrook B, et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38–46.
   PubMed Web of Science ®Google Scholar
• Dibley L, Norton C. Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis. 2013;19(7):1450–1462.
   PubMed Web of Science ®Google Scholar
• Norton C, Chelvanayagam S, Wilson-Barnett J, et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125(5):1320–1329.
   PubMed Web of Science ®Google Scholar
• Rao SSC, Benninga MA, Bharucha AE, et al. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil. 2015;27(5):594–609.
   PubMed Web of Science ®Google Scholar
• Khera AJ, Chase JW, Salzberg M, et al. Systematic review: pelvic floor muscle training for functional bowel symptoms in inflammatory bowel disease. JGH Open. 2019;3(6):494–507.
   PubMed Web of Science ®Google Scholar
• Khera AJ, Chase JW, Salzberg M, et al. Gut-directed pelvic floor behavioral treatment for fecal incontinence and constipation in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(3):620–626.
   PubMed Web of Science ®Google Scholar
• Gordon S, Ameen V, Bagby B, et al. Validation of irritable bowel syndrome global improvement scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci. 2003;48(7):1317–1323.
   PubMed Web of Science ®Google Scholar
• Vaizey CJ, Carapeti E, Cahill JA, et al. Prospective comparison of faecal incontinence grading systems. Gut. 1999;44(1):77–80.
   PubMed Web of Science ®Google Scholar
• Frank L, Kleinman L, Farup C, et al. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999;34:870–877.
   PubMed Web of Science ®Google Scholar
• Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96(3):804–810.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. Euroqol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Broadbent E, Petrie KJ, Main J, et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637.
   PubMed Web of Science ®Google Scholar
• Keefer L, Kiebles JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis. 2011;17(2):614–620.
   PubMed Web of Science ®Google Scholar
• Beer-Gabel M, Carter D. Comparison of dynamic transperineal ultrasound and defecography for the evaluation of pelvic floor disorders. Int J Colorectal Dis. 2015;30(6):835–841.
   PubMed Web of Science ®Google Scholar
• Dietz HP, Jarvis SK, Vancaillie TG. The assessment of levator muscle strength: a validation of three ultrasound techniques. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(3):156–159.
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2015;12(8):472–485.
   PubMed Web of Science ®Google Scholar
• Thibault-Gagnon S, McLean L, Goldfinger C, et al. Differences in the biometry of the levator hiatus at rest, during contraction, and during valsalva maneuver between women with and without provoked vestibulodynia assessed by transperineal ultrasound imaging. J Sex Med. 2016;13(2):243–252.
   PubMed Web of Science ®Google Scholar
• Jelsness-Jorgensen LP, Bernklev T, Henriksen M, et al. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(1):106–114.
   PubMed Web of Science ®Google Scholar
• Graff LA, Sexton KA, Walker JR, et al. Validating a measure of patient self-efficacy in disease self-management using a population-based ibd cohort: the IBD self-efficacy scale. Inflamm Bowel Dis. 2016;22(9):2165–2172.
   PubMed Web of Science ®Google Scholar
• Mazor Y, Prott G, Jones M, et al. Factors associated with response to anorectal biofeedback therapy in patients with fecal incontinence. Clin Gastroenterol Hepatol. 2021;19(3):492–502 e5.
   PubMedGoogle Scholar
• Patcharatrakul T, Valestin J, Schmeltz A, et al. Factors associated with response to biofeedback therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2018;16(5):715–721.
   PubMed Web of Science ®Google Scholar